BioSpace News Archive

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today reported its financial results for the first quarter ended March 31, 2021.

CYduct Diagnostics, Inc. is pleased to announce it has signed and closed an agreement to acquire all the assets of HHC PREFERRED LLC.

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today disclosed the first efficacy and safety data from a small cohort of patients in its ongoing Phase 1b clinical trial of its lead candidate mavorixafor

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and vision applications, today announced that it has been selected as the ‘Best Overall Medical Device Company’ in the MedTech Breakthrough Awards.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced that mitapivat clinical data will be presented at the European Hematology Association (EHA) Annual Congress being held virtually June 9-17, 2021.

New Oxbryta® (voxelotor) Data from Phase 2a HOPE-KIDS 1 Study Demonstrate Improvement in Hemoglobin and Hemolysis in Children Ages 4 to 11 Years with Sickle Cell Disease

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced an abstract presentation related to AUTO1 in relapsed / refractory (r/r) indolent B cell lymphomas (IBCL) at the European Hematology Association (EHA) Virtual Congress to be held June 9-17, 2021.

Immunizations are one of the most important things parents can do to keep their kids healthy as they go back to school and enroll in summer activities

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical results from its broad hematology program will be presented at the 26 th European Hematology Association 2021 (EHA2021) Virtual Congress being held June 9 – 17, 2021.

Milestone Scientific Inc. (NYSE American: MLSS) , a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, May 17, 2021 to discuss the Company’s financial results for the first quarter ended March 31, 2021, as well as the Company’s corporate progress and other developments.